Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 148, 60-69
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- European Research Council (PoC SAVEBRAIN '737586)
- Horizon 2020 Framework Programme (2020)
- Horizon 2020
This publication has 55 references indexed in Scilit:
- The NOX toolbox: validating the role of NADPH oxidases in physiology and diseaseCellular and Molecular Life Sciences, 2012
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Signal transduction by reactive oxygen speciesJournal of Cell Biology, 2011
- NOX1, 2, 4, 5: counting out oxidative stressBritish Journal of Pharmacology, 2011
- A Novel and Specific NADPH Oxidase-1 (Nox1) Small-Molecule Inhibitor Blocks the Formation of Functional Invadopodia in Human Colon Cancer CellsACS Chemical Biology, 2010
- Comparative pharmacology of chemically distinct NADPH oxidase inhibitorsBritish Journal of Pharmacology, 2010
- Calcium-Dependent NOX5 Nicotinamide Adenine Dinucleotide Phosphate Oxidase Contributes to Vascular Oxidative Stress in Human Coronary Artery DiseaseJACC, 2008
- The relationship between dose of vitamin E and suppression of oxidative stress in humansFree Radical Biology and Medicine, 2007
- NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generationBiochemical Journal, 2007
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007